Reich, K.; Kristensen, L. E.; Smith, S. D. .; Rich, P.; Sapin, C.; Liu Leage, S.; McKenzie, R.; Schuster, C.; Riedl, E.; Gooderham, M. Efficacy and Safety of Ixekizumab Versus Adalimumab in Patients With Active Psoriatic Arthritis and Moderate-to-Severe Psoriasis: 52-Week Results from the Randomised SPIRIT-H2H Trial. Dermatol Pract Concept 2022, 12 (2), e2022104. https://doi.org/10.5826/dpc.1202a104.